Acting Minister of Health Nguyen Thanh Long |
According to the World Health Organization, as of September 24, 187 COVID-19 vaccines are in development across the world of which 38 are undergoing clinical trials, while 149 others are in pre-clinical research.
Mr. Long revealed that Viet Nam is one of 92 countries participating in the COVAX Facility – a Gavi-coordinated pooled procurement mechanism for new COVID-19 vaccines – and is committed to support from Gavi COVAX AMC.
With the goal of supplying 2 billion doses of a vaccine to countries by the end of 2021, accounting for about 20% of the population of the member countries of the COVAX Facility, Viet Nam will have the opportunity to access and be provided vaccines from the catalogue of COVAX AMC, said the Acting Minister.
The Vietnamese Ministry of Health has directed domestic manufacturers to increase vaccine research and production activities. The four leading Vietnamese manufacturers are concentrating their resources and efforts on this work, with an aim of having at least one manufacturer capable of conducting clinical trials in the second and third phase in 2021. So far, Vietnamese COVID-19 vaccine candidates are currently tested on mice.
Besides the two possible supplies of vaccines (COVAX Facility) and the above-mentioned domestically produced vaccine source, Viet Nam has also actively looking for other sources of vaccines through direct contact with manufacturers abroad. Previously, Viet Nam ordered to purchase COVID-19 vaccine from Russia, the U.S. and UK.
In parallel with the search for vaccine supply, the ministry has also prepared legal bases to promote testing procedures and circulation registration for possible COVID 19 vaccines, Mr. Long said.
So far, Viet Nam has confirmed 1,095 cases of COVID-19 and 35 deaths. There has been no local transmission in nearly a month./.
By Kim Loan